This page exists as a resource for UK-based formulators, product developers, and procurement teams who need accurate, up-to-date information on what can be legally imported, how terpenes fit into the UK regulatory framework, and what to expect when sourcing from a US supplier.
Are Terpenes Legal in the United Kingdom?
The short answer is yes. Isolated terpenes are fully legal to purchase, possess, and use in the United Kingdom. They are not classified as controlled substances under the Misuse of Drugs Act 1971 and carry none of the restrictions that apply to cannabinoids like Delta-9 THC or cannabinol. The confusing part here is how the UK’s cannabis and hemp regulations interact with terpene-containing products more broadly.
Isolated terpenes are aromatic hydrocarbon compounds. They contain no cannabinoids. They are not derived from controlled parts of the cannabis plant in any way that places them under the MDA 1971 or the Misuse of Drugs Regulations 2001.
They are the same class of molecules found in citrus peel, pine needles, lavender, and black pepper, which are widely used across the food, fragrance, and cosmetics industries.
When those terpenes happen to be extracted from cannabis or hemp flower, they carry the same legal status as their botanical equivalents, provided they contain no residual THC or other controlled cannabinoids.
What the 0.2% THC Threshold Means
This is one of the most commonly misread figures in the UK cannabis and hemp space. The 0.2% THC threshold applies to hemp cultivation, specifically, it governs the approved seed varieties that licensed growers may legally cultivate in the UK under a Home Office licence. It is not the legal limit for finished products.
For finished products sold or imported into the UK, the relevant threshold under the Misuse of Drugs Regulations 2001 is no more than 1mg of controlled cannabinoids per container under the Exempt Product Definition (EPD).
This includes products that contain trace levels of THC or other controlled cannabinoids. If a product meets this threshold, it may be supplied without a Home Office-controlled drugs licence. Products that exceed it require a licence. This distinction matters enormously for formulators building products around terpenes, because the compliance question is about the finished container and not the concentration percentage.
Isolated terpenes from a clean, solvent-free extraction process and verified by GC-MS analysis to contain no detectable THC or other cannabinoids do not fall under this framework at all. They are not controlled products. The 1mg EPD threshold is only relevant when terpenes are blended into a product that also contains cannabinoids.
Hemp Cultivation Licensing in the UK (2025–2026 Updates)
UK hemp cultivation is legal but strictly licensed. Growers must obtain a controlled drugs domestic licence from the Home Office before planting. As of the 2025 growing season, the Home Office expanded cultivation permissions to allow farm businesses to grow hemp anywhere within the extent of a licensed farm, rather than only on specifically designated plots. Licences issued for the 2025 season are valid for three growing seasons; from the 2026 season onward, licences extend to six growing seasons provided growers maintain compliance.
Only EU/UK-approved seed varieties with THC content below 0.2% may be legally cultivated.
Historically, only the fiber and seeds could be processed commercially and flowers and leaves were required to be destroyed. This restriction continues to shape why the UK import market for cannabis-derived terpenes exists: domestically sourced CDTs are not commercially viable at scale because flower processing remains restricted, making California-grown terpenes a practical and high-quality alternative for UK formulators.
The UK Regulatory Framework: At a Glance
UK formulators working with cannabis-adjacent inputs need to track several overlapping regulatory bodies and pieces of legislation. The framework below covers what is most relevant to terpene procurement and product formulation.
Key legislation and regulatory bodies:
- Misuse of Drugs Act 1971 (MDA): The primary legislation governing controlled substances in the UK. Cannabis is a Class B controlled drug under the MDA. Isolated terpenes are not controlled under this Act.
- Misuse of Drugs Regulations 2001 (MDR 2001): Establishes the Exempt Product Definition (EPD), which sets the 1mg controlled cannabinoid per container threshold for products that may be supplied without a licence.
- Food Standards Agency (FSA): Regulates CBD and hemp-derived products intended for ingestion as novel foods. Terpenes added as flavouring or aromatic compounds to food and beverage products may fall under food law depending on their application and concentration.
- Medicines and Healthcare Products Regulatory Agency (MHRA): Any product that makes a medicinal claim is considered a medicinal product under the Human Medicines Regulations 2012 and requires a Marketing Authorisation. This applies regardless of whether the active ingredient is a cannabinoid or terpene.
- UK Cosmetics Product Safety Regulations: Terpenes used in topical applications (balms, creams, skincare) must comply with cosmetic safety requirements and be listed on the UK Cosmetic Product Notification Portal (CPNP).
CBD and the Novel Food Framework: What Formulators Need to Know
Since January 2019, CBD extracts and isolates have been classified as novel foods in the UK, requiring pre-market authorisation from the FSA before they can legally be placed on the UK market. As of mid-2026, no CBD extract or isolate has yet received full novel food authorisation, though several applications have received positive safety assessments and the FSA launched its first public consultation on proposed CBD authorisations in August 2025.
Products that were on the market before 13 February 2020 and submitted a validated application to the FSA by 31 March 2021 may continue to be sold while awaiting authorisation, provided they appear on the FSA’s Public List. Products introduced after 13 February 2020 require full authorisation before they can legally be sold.
The FSA has also removed over 100 products from the public list for failing to progress their applications, signalling that enforcement posture is becoming more active.
This matters directly to formulators in two ways.
- First, if you are developing a CBD food supplement, drink, or edible and plan to use terpenes as part of the formulation, the novel food requirements apply to the CBD component, not the terpenes themselves. Terpenes used as flavouring additives operate under separate food law provisions.
- Second, the FSA’s current guidance recommends that CBD products contain no more than 10mg of CBD per day (the provisional acceptable daily intake, or ADI) and no more than 70µg of Delta-9 THC per day as a safe upper limit. These figures are advisory rather than legally binding, but products significantly exceeding them face elevated scrutiny during the authorisation process.
Application Areas: How Terpenes Fit UK Product Categories
The regulatory path for a terpene-containing product in the UK depends almost entirely on how that product is positioned, applied, and marketed. Below is a breakdown of the most common categories UK formulators work with.
Inhalable Products: Vape and E-Liquid
Cannabis-derived terpenes are legal in UK vape and e-liquid formulations provided the finished product contains no more than 1mg of controlled cannabinoids per container under the MDR 2001 Exempt Product Definition.
Vape products also fall under the Tobacco and Related Products Regulations 2016 (TRPR) if they contain nicotine, but CBD and terpene e-liquids that are nicotine-free operate outside TRPR scope.
In practice, this means that formulators using isolated, THC-free terpenes in e-liquids face no cannabinoid compliance issue at all. The terpenes themselves are inert from a controlled substance standpoint. Compliance risk only emerges if residual cannabinoids are present, which is why COA documentation verifying cannabinoid absence is standard practice for any professional supply chain.
Key considerations for vape formulators:
- Verify that terpene COAs show non-detectable THC via ISO/IEC 17025-accredited GC-MS analysis
- Confirm no residual hydrocarbon solvents. Butane and propane extraction leave residue profiles that create both safety risks and analytical red flags under UK testing
- Keep terpene addition rates within the 1–5% range by volume; higher concentrations create viscosity and irritancy issues in inhalable formats
- Finished product labelling should include appropriate safety warnings for under-18s, pregnant women, and those on medication
Ingested Products: Supplements, Edibles, and Beverages
When terpenes are added to food or beverage products as flavouring or aromatic compounds, they generally fall under food additive and flavouring regulations rather than the novel food framework.
Terpenes with GRAS (Generally Recognized as Safe) status in the US, including limonene, linalool, myrcene, and beta-caryophyllene, have established safety profiles that align with UK food law. They are used extensively in the conventional flavouring industry.
The novel food requirement applies to the CBD component if one is present. The terpene component is treated separately. This means a beverage developer adding cannabis-derived terpenes for flavour — without any CBD extract — does not trigger the novel food application process for the terpenes. Their compliance obligation is under food safety and flavouring law, not the FSA’s CBD novel food framework.
If the same beverage contains CBD, the formulator must ensure the CBD ingredient is on the FSA’s Public List and is progressing toward authorisation. The terpene component remains outside that requirement. For more detail on formulating terpene-infused beverages, our technical guide covers emulsification, pasteurisation stability, and dosing considerations.
Topical and Cosmetic Products
Terpenes in topical applications, balms, serums, massage oils, and skincare are regulated under UK cosmetic product safety regulations. Products must undergo a UK Cosmetics Product Safety Report (CPSR) conducted by a qualified safety assessor before being placed on the market, and must be registered on the UK CPNP. There is no novel food requirement and no MDA consideration for purely topical products with no ingestion pathway.
Common terpenes used in topical formulations, linalool, beta-caryophyllene, pinene, terpinolene are well-established in the cosmetics industry and have extensive safety data. Formulators should note that some terpenes are classified as potential skin sensitisers under cosmetic regulations at higher concentrations and may require labelling at or above certain thresholds.
Aromatherapy and Non-Ingested Wellness Products
Isolated terpenes used in aromatherapy diffusers, candles, room sprays, and non-ingested wellness products fall outside the food, medicine, and controlled substance frameworks entirely. They operate as standard aromatic compounds. No specialist regulatory pathway applies beyond general product safety obligations.
Importing Terpenes from the United States to the UK
Importing isolated, THC-free cannabis-derived terpenes from the United States to the United Kingdom is legal and straightforward compared to importing cannabinoid-containing products.
Because isolated terpenes contain no controlled substances, they are not subject to import restrictions under the MDA 1971. They cross borders as aromatic compounds or flavouring ingredients, which is the same classification used for botanical terpenes sourced from citrus, pine, or lavender.
The documentation that makes this process smooth:
- Certificate of Analysis (COA): Issued by an ISO/IEC 17025-accredited laboratory, confirming terpene composition and verifying that controlled cannabinoids (THC, CBN, and analogues) are non-detectable. This is the single most important document at customs.
- Extraction Method Documentation: Records confirming that no hydrocarbon solvents (butane, propane) were used in production. Steam distillation or cold-trap methods produce no solvent residue profile.
- Product Specification Sheet: Outlines the intended use which determines the applicable import classification.
- Country of Origin Documentation: Confirms the product is hemp-derived and produced under compliant US agricultural conditions.
A common point of confusion arises when importers conflate cannabis-derived terpenes with cannabis extracts or CBD products. They are different product categories.
Cannabis extracts containing cannabinoids require far more scrutiny at the UK border. Isolated terpenes, properly documented and tested, do not. UK customs classifies them based on their chemical nature and intended use — not their botanical origin.
It is worth noting that the law firm Kingsley Napley has confirmed there are no strict requirements for importing and selling CBD products in the UK if the content of THC in them is below the detection limit. For pure isolated terpenes, which contain no cannabinoids at all, the bar is even lower.
Why Terpene Belt Farms Ships Reliably to the UK
Most terpene suppliers are not built for international B2B. Minimum orders are too high, documentation is incomplete, and supply chains break down when volume scales. UK formulators sourcing premium cannabis-derived terpenes face an additional layer of complexity because the product category still generates compliance questions at the buyer’s end — even when everything is legal.
Terpene Belt Farms was built specifically to address these gaps. Every batch we produce goes through third-party GC-MS and GC-FID analysis at ISO/IEC 17025-accredited laboratories, producing COAs that name every detected compound and confirm non-detectable THC. Our Fresh Never Frozen® methodology means terpenes are extracted immediately post-harvest and never exposed to freeze-thaw cycles that degrade volatile compounds. What arrives at your facility is the same profile that left the plant.
Our extraction process avoids hydrocarbon solvents entirely. There is no butane, no propane, no residual solvent profile on our COAs, which matters both for product safety and for import documentation. We produce terpenes as aromatic compounds, not as cannabis extracts, and our paperwork reflects that distinction clearly.
For UK wholesale partners, we provide full documentation packages including COAs, specification sheets, and extraction method records. If your procurement or legal team needs anything specific for internal compliance sign-off, our team works through it with you before the first order ships.
Request a wholesale quote or start with a sample kit to run your own R&D before committing to volume.
Frequently Asked Questions About Terpenes and UK Regulations
Are Cannabis-Derived Terpenes Legal to Import Into the UK?
Yes. Isolated, THC-free cannabis-derived terpenes are legal to import into the UK. They are not classified as controlled substances under the Misuse of Drugs Act 1971 and carry no import restrictions applicable to cannabinoid-containing products. The relevant condition is that they contain no detectable THC or other controlled cannabinoids, which is verified through COA documentation from an ISO/IEC 17025-accredited laboratory. Properly documented isolated terpenes cross UK customs as aromatic or flavouring compounds.
What Is the UK THC Limit for Finished Products?
The commonly cited 0.2% THC figure applies to hemp cultivation seed varieties, not to finished products. The legal threshold for finished products under the Misuse of Drugs Regulations 2001 (Regulation 2, Exempt Product Definition) is no more than 1mg of controlled cannabinoids per container, regardless of product volume or weight. Products exceeding this threshold require a Home Office controlled drugs licence to be supplied. Isolated terpenes that contain no cannabinoids are not subject to this threshold at all.
Do I Need to Register My Terpene Product with the FSA?
Not if terpenes are used as flavouring or aromatic ingredients. The FSA’s novel food framework applies specifically to CBD extracts, CBD isolates, and products that contain them. Terpenes used as flavourings in food or beverages operate under food flavouring law, not novel food regulations. If your product contains CBD alongside terpenes, the CBD component triggers the novel food requirement — but the terpene component does not. Always confirm with a UK food law consultant for your specific formulation.
Can Terpenes Be Used in UK Vape Products Legally?
Yes. Cannabis-derived terpenes are legal in UK vape and e-liquid formulations provided the finished product contains no more than 1mg of controlled cannabinoids per container. Isolated, THC-free terpenes contain no controlled cannabinoids, so there is no compliance barrier under the MDA framework. Formulators should verify non-detectable THC via COA, confirm absence of residual hydrocarbon solvents, and keep terpene concentrations within safe inhalation ranges. Vape products are not subject to TRPR unless they contain nicotine.
What Documentation Do I Need When Ordering Terpenes from a US Supplier?
The core documentation required is a Certificate of Analysis (COA) from an ISO/IEC 17025-accredited laboratory confirming terpene composition and non-detectable controlled cannabinoids. Supporting documents include a product specification sheet identifying the intended use category (flavouring, aromatic, cosmetic ingredient), extraction method records confirming no hydrocarbon solvents, and country of origin documentation. This package addresses the questions UK customs and your internal compliance team are most likely to raise.
Are Terpenes Considered Novel Foods in the UK?
No. Terpenes are not classified as novel foods by the Food Standards Agency. The novel food designation applies to CBD extracts, CBD isolates, and products containing them. Terpenes have a long history of use as flavourings and aromatic compounds in conventional food and beverage production — well before the May 1997 threshold used to establish novel food status. They fall under food flavouring law when used in edible products, not the novel food authorisation pathway.
Sources for this Article
- UK Legislation: “Misuse of Drugs Act 1971” – legislation.gov.uk/ukpga/1971/38/contents
- UK Legislation: “The Misuse of Drugs Regulations 2001 – Regulation 2” – legislation.gov.uk/uksi/2001/3998/regulation/2/made
- Food Standards Agency: “Cannabidiol (CBD)” – food.gov.uk/business-guidance/cannabidiol-cbd
- Kingsley Napley: “Importing CBD products” – kingsleynapley.co.uk/resources/download/404/importing-cbd-products.pdf
